We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » U.S. Suspends Distribution of Eli Lilly COVID-19 Antibody Cocktail
U.S. Suspends Distribution of Eli Lilly COVID-19 Antibody Cocktail
HHS has stopped shipping Eli Lilly’s COVID-19 antibody cocktail (bamlanivimab/etesevimab) because of the therapy’s lack of effectiveness against new variants of SARS-CoV-2.